EUVIMEDEUVIMED entdecken
Open Access

Prebiotics Rescue Gut Microbiome Dysregulation and Enhance Cognitive and Gastrointestinal Function in a Mouse Model of Schizophrenia

Carolina Gubert, Geraldine Kong, Sheida Shadani, Sasha Connell, Bethany A Masson, Nicholas van de Garde, Vinod K Narayana, Thibault Renoir, Anthony J Hannan iD

Schizophrenia Bulletin · 2025

DOI: 10.1093/schbul/sbaf056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2025. Verfasst von Carolina Gubert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Schizophrenia, Prebiotics, Oligosaccharides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bethlehem Griffiths Research Foundation (BGRF) Grant, National Health and Medical Research Council (NHMRC) Principal Research Fellowship and Ideas Grant, EU-JPND Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Schizophrenia is a devastating psychiatric disorder characterized by positive (eg, hallucinations) and negative (eg, reduced motivation) symptoms, and cognitive deficits. Chronic gastrointestinal tract issues exist as comorbid symptoms of schizophrenia. Recent findings indicate the involvement of the microorganisms that inhabit the gut, the microbiota (and the broader microbiome which also includes microbial genomes, etc.) in schizophrenia pathogenesis. In the present study, we hypothesized that chronic administration with prebiotics fructooligosaccharide and galactooligosaccharide (FOS and GOS; a combination used clinically for other disorders) would restore gut microbiome composition of the metabotropic glutamate receptor 5 (mGlu5) knockout (KO) mouse model of schizophrenia, which we previously demonstrated to exhibit gut dysbiosis. Study Design We assessed the impact of prebiotics on gut microbiome composition and function, as well as the gastrointestinal function and schizophrenia-like phenotype of mGlu5 KO mice and wild-type littermates. We administered a combination of the prebiotics FOS and GOS, vs vehicle control administration, in both the mouse model of schizophrenia and wild-type littermates. Study Results The present study firstly corroborated the altered gut microbiome composition in the mGlu5 KO mouse model of schizophrenia. Importantly, we have revealed an altered microbial metabolic profile. We have also shown that the prebiotics we administered were not only able to rescue these gut microbiome changes but also had additional beneficial effects including cognitive enhancement and improved gastrointestinal function. Conclusion These preclinical findings indicate that prebiotics, such as the combination of FOS and GOS used in the present study, may have therapeutic potential in schizophrenia as an add-on intervention with an exceptional safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeSchizophreniaPrebioticsOligosaccharidesDysbiosisCognitive DysfunctionAnimalsDisease Models, AnimalMiceMice, KnockoutMaleBehavior, Animal

Stichwörter der Autor:innen

fructooligosaccharidegalactooligosaccharidegut microbiomemGlu5 KO miceprebioticsschizophrenia

Substanzen

PrebioticsOligosaccharidesfructooligosaccharide

Autor:innen und Institutionen

  • Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia.
  • Peter Doherty Institute of Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia.
  • Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia.
  • Metabolomics Australia Bio21 Institute and Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3052, Australia.
  • Department of Anatomy and Physiology, University of Melbourne, Parkville, Victoria 3010, Australia.

ORCID-Profile: Anthony J Hannan

Förderung

  • Bethlehem Griffiths Research Foundation (BGRF) Grant
  • National Health and Medical Research Council (NHMRC) Principal Research Fellowship and Ideas Grant
  • EU-JPND Grant
  • DHB Foundation
  • Equity Trustees
  • Flicker of Hope Foundation
  • NHMRC Project Grants
  • NHMRC Dementia Fellowship

Zitieren

APA

Gubert, C., Kong, G., Shadani, S., Connell, S., Masson, B. A., van de Garde, N., Narayana, V. K., Renoir, T., & Hannan, A. J. (2025). Prebiotics Rescue Gut Microbiome Dysregulation and Enhance Cognitive and Gastrointestinal Function in a Mouse Model of Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf056

Vancouver

Gubert C, Kong G, Shadani S, Connell S, Masson BA, van de Garde N, et al. Prebiotics Rescue Gut Microbiome Dysregulation and Enhance Cognitive and Gastrointestinal Function in a Mouse Model of Schizophrenia. Schizophrenia Bulletin. 2025. doi:10.1093/schbul/sbaf056

BibTeX
@article{Gubert2025,
  author = {Gubert, Carolina and Kong, Geraldine and Shadani, Sheida and Connell, Sasha and Masson, Bethany A and van de Garde, Nicholas and Narayana, Vinod K and Renoir, Thibault and Hannan, Anthony J},
  title = {Prebiotics Rescue Gut Microbiome Dysregulation and Enhance Cognitive and Gastrointestinal Function in a Mouse Model of Schizophrenia},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  doi = {10.1093/schbul/sbaf056}
}
Kostenlos starten →